Glypican-1 as a novel immunotherapeutic target in prostate cancer.

被引：4
|
作者：
Zaslavsky, Alexander
Adams, Mackenzie
Wissmueller, Sandra
Campbell, Douglas
Klingemann, Hans
Walsh, Brad
Palapattu, Ganesh S.
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Minom Int Ltd, Macqaurie Pk, Australia
[3] Minom Int Ltd, Sydney, NSW, Australia
[4] NantKwest Inc, Culver City, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 06期
关键词：
D O I：
10.1200/JCO.2018.36.6_suppl.174
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
174
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Glypican-1 Overexpression in Different Types of Breast Cancers
    Alshammari, Fatemah O. F. O.
    Al-Saraireh, Yousef M.
    Youssef, Ahmed M. M.
    Al-Sarayra, Yahya M.
    Alrawashdeh, Hamzeh Mohammad
    ONCOTARGETS AND THERAPY, 2021, 14 : 4309 - 4318
  • [42] Glypican-1 facilitates prion conversion in lipid rafts
    Hooper, Nigel M.
    JOURNAL OF NEUROCHEMISTRY, 2011, 116 (05) : 721 - 725
  • [43] Glypican-1 immunohistochemistry is a novel marker to differentiate epithelioid mesothelioma from lung adenocarcinoma
    Amatya, Vishwa Jeet
    Kushitani, Kei
    Kai, Yuichiro
    Suzuki, Rui
    Miyata, Yoshihiro
    Okada, Morihito
    Takeshima, Yukio
    MODERN PATHOLOGY, 2018, 31 (05) : 809 - 815
  • [44] Crystal Structure of N-Glycosylated Human Glypican-1 Core Protein STRUCTURE OF TWO LOOPS EVOLUTIONARILY CONSERVED IN VERTEBRATE GLYPICAN-1
    Svensson, Gabriel
    Awad, Wael
    Hakansson, Maria
    Mani, Katrin
    Logan, Derek T.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (17) : 14040 - 14051
  • [45] Immunohistochemical expression of glypican-1 in the differents types of ameloblastomas
    Bologna-Molina, Ronell
    Molina-Frechero, Nelly
    Pelaez-Marciglia, Arleth
    Gonzalez-Gonzalez, Rogelio
    ORAL ONCOLOGY, 2013, 49 : S125 - S125
  • [46] Improving the diffraction of glypican-1 crystals by controlled dehydration
    Awad, W.
    Birkedal, G.
    Thunnissen, M.
    Mani, K.
    Logan, D.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2014, 70 : C321 - C321
  • [47] TREX1 as a Novel Immunotherapeutic Target
    Hemphill, Wayne O.
    Simpson, Sean R.
    Liu, Mingyong
    Salsbury, Freddie R., Jr.
    Hollis, Thomas
    Grayson, Jason M.
    Perrino, Fred W.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [48] PSMA targeting CAR T cell immunotherapeutic strategy for prostate cancer.
    Gonzalez-Valdivieso, Juan
    Yang, Yanping
    Vedvyas, Yogindra
    Alcaina, Yago
    Jin, Moonsoo M.
    CANCER RESEARCH, 2022, 82 (12)
  • [49] The Glypican-1/HGF/C-Met and Glypican-1/VEGF/VEGFR2 Ternary Complexes Regulate Hair Follicle Angiogenesis
    Colin-Pierre, Charlie
    Berthelemy, Nicolas
    Belloy, Nicolas
    Danoux, Louis
    Bardey, Vincent
    Rivet, Romain
    Mine, Solene
    Jeanmaire, Christine
    Maquart, Francois-Xavier
    Ramont, Laurent
    Brezillon, Stephane
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [50] Evaluation of an immunotherapeutic DNA-vaccine in biochemically relapsed prostate cancer.
    Shore, Neal D.
    Heath, Elisabeth I.
    Nordquist, Luke T.
    Cheng, Heather H.
    Bhatt, Kamalnayan
    Morrow, Matthew
    McMullan, Trevor
    Kraynyak, Kimberly
    Lee, Jessica
    Sacchetta, Brian
    Liu, Li
    Rosencranz, Samantha
    Tagawa, Scott T.
    Parikh, Rahul Atul
    Tutrone, Ronald F.
    Garcia, Jorge A.
    Whang, Young E.
    Kelly, William Kevin
    Csiki, Ildiko
    Bagarazzi, Mark L.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345